ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
enGene Holdings Inc

enGene Holdings Inc (ENGN)

3.33
0.08
(2.46%)
3.33
0.00
(0.00%)

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
3.33
Bid
3.06
Ask
3.34
Volume
48,045
3.22 Day's Range 3.44
2.65 52 Week Range 11.00
Market Cap
Previous Close
3.25
Open
3.28
Last Trade
5
@
3.3399
Last Trade Time
Financial Volume
$ 158,341
VWAP
3.2957
Average Volume (3m)
73,456
Shares Outstanding
50,977,560
Dividend Yield
-
PE Ratio
-3.08
Earnings Per Share (EPS)
-1.08
Revenue
-
Net Profit
-55.14M

About enGene Holdings Inc

enGene Holdings Inc. is a holding company. The Company, through its subsidiary, enGene Inc., is engaged in developing non-viral gene therapies based on localized delivery of nucleic acid payloads to mucosal tissues. The Company's proprietary dually derived chitosan (DDX) platform has a high degree o... enGene Holdings Inc. is a holding company. The Company, through its subsidiary, enGene Inc., is engaged in developing non-viral gene therapies based on localized delivery of nucleic acid payloads to mucosal tissues. The Company's proprietary dually derived chitosan (DDX) platform has a high degree of payload flexibility, including DNA and various forms of RNA with broad tissue and disease application. In preclinical animal and in vitro models, the Company's DDX technology has been demonstrated to effectively induce expression of therapeutic genes following delivery to the lung, gastrointestinal tract, and urinary tract, and its lead product detalimogene voraplasmid (EG-70) is being developed for the treatment of bacillus calmette-guerin (BCG)-resistant non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS). EG-70 is a novel non-viral gene therapy designed to elicit a local immune response following the delivery to the bladder urothelium. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
Headquarters
Quebec City, Quebec, Can
Founded
-
enGene Holdings Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker ENGN. The last closing price for enGene was $3.25. Over the last year, enGene shares have traded in a share price range of $ 2.65 to $ 11.00.

enGene currently has 50,977,560 shares outstanding. The market capitalization of enGene is $165.68 million. enGene has a price to earnings ratio (PE ratio) of -3.08.

ENGN Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.27-7.53.64.06022.91533793.30516641CS
4-0.1-2.915451895043.434.462.9820513.63691627CS
12-1.85-35.71428571435.185.332.65734563.70033844CS
26-3.4206-50.67105146216.75068.442.65965575.54500926CS
52-6.64-66.59979939829.97112.651248056.89755422CS
156-13.66-80.400235432616.99432.651013618.34985663CS
260-13.66-80.400235432616.99432.651013618.34985663CS

ENGN - Frequently Asked Questions (FAQ)

What is the current enGene share price?
The current share price of enGene is $ 3.33
How many enGene shares are in issue?
enGene has 50,977,560 shares in issue
What is the market cap of enGene?
The market capitalisation of enGene is USD 165.68M
What is the 1 year trading range for enGene share price?
enGene has traded in the range of $ 2.65 to $ 11.00 during the past year
What is the PE ratio of enGene?
The price to earnings ratio of enGene is -3.08
What is the reporting currency for enGene?
enGene reports financial results in USD
What is the latest annual profit for enGene?
The latest annual profit of enGene is USD -55.14M
What is the registered address of enGene?
The registered address for enGene is 4868 RUE LEVY, SUITE 220, SAINT-LAURENT, QUEBEC CITY, QUEBEC, H4R 2P1
What is the enGene website address?
The website address for enGene is www.engene.com/
Which industry sector does enGene operate in?
enGene operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
RBNERobin Energy Ltd
$ 13.85
(313.43%)
101.81M
OPOceanPal Inc
$ 1.63
(125.45%)
80.28M
LGHLWLion Group Holding Ltd
$ 0.0052
(116.67%)
6.87M
NEONNeonode Inc
$ 16.83
(68.47%)
4.78M
ICONIcon Energy Corporation
$ 2.90
(62.01%)
59.04M
SBETSharpLink Gaming Inc
$ 9.2275
(-71.63%)
41.92M
AIHSSenmiao Technology Ltd
$ 0.381
(-63.01%)
16.8M
CHSNChanson International Holding
$ 0.22
(-60.00%)
15.15M
KWMK Wave Media Ltd
$ 2.91
(-50.43%)
2.59M
JZXNJiuzi Holdings Inc
$ 1.56
(-46.39%)
2.24M
HCTIHealthcare Triangle Inc
$ 0.0201
(-33.00%)
856.89M
GNLNGreenlane Holdings Inc
$ 0.0101
(-34.42%)
792.34M
CGBSCrown LNG Holdings Ltd
$ 0.1104
(31.43%)
788.42M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 12.655
(3.81%)
246.13M
NVDANVIDIA Corporation
$ 141.97
(-2.09%)
180.81M

Your Recent History

Delayed Upgrade Clock